Adherence, Discontinuation, and Switching of Biologic Therapies in Medicaid Enrollees with Rheumatoid Arthritis

Author： Li Pengxiang   Blum Marissa A.   Von Feldt Joan   Hennessy Sean   Doshi Jalpa A.  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.6, 2010-09, pp. : 805-812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 542-548

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Rheumatoid Arthritis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 752-759

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Agents for Treatment of Rheumatoid Arthritis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-03 ,pp. : 8-23

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Agents in the Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 3, 2000-11 ,pp. : 217-233

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for rheumatoid arthritis

By Jacques Peggy   Van den Bosch Filip  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 231-244

Informa Healthcare

Access to resources Recommend Favorite